| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Allophycocyanin | NBP1-42995 | |||
| Biotin | NBP1-43546-0.5mg | |||
| Biotin | NBP1-43546-0.1mg | |||
| FITC | NBP1-43947-0.05mg | |||
| PE | NBP1-43763-0.2mg | |||
| PE | NBP1-43763-0.1mg | |||
| PE | NBP1-43763-0.05mg | |||
| PE/Cy5 | NBP1-43068-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43303-0.1mg | |||
| BSA Free | NBP1-43303-0.025mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Allophycocyanin | NBP1-42995 | |||
| Biotin | NBP1-43546-0.1mg | |||
| FITC | NBP1-43947-0.05mg | |||
| PE | NBP1-43763-0.2mg | |||
| PE | NBP1-43763-0.1mg | |||
| PE | NBP1-43763-0.05mg | |||
| PE/Cy5 | NBP1-43068-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.1mg | |||
| PE/Cy7 | NBP1-42940-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43303-0.5mg | |||
| BSA Free | NBP1-43303-0.1mg | |||
| BSA Free | NBP1-43303-0.025mg | |||
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy7 conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 micrograms of Rat IgG2a ? Isotype Control PE-Cy7 (left) or 0.06 micrograms of Anti-Mouse IgM PE-Cy7 (right). Cells in the ly](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0008.jpg "Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy7 conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 micrograms of Rat IgG2a ? Isotype Control PE-Cy7 (left) or 0.06 micrograms of Anti-Mouse IgM PE-Cy7 (right). Cells in the ly")
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Staining of C57BL/6 splenocytes with 0.5 ug of Rat IgG2a kappa Isotype Control Purified (open histogram) or 0.5 ug of Anti-Mouse IgM Purified (filled histogram) followed by Anti-Rat IgG Biotin and Streptavidin PE. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0001.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Allophycocyanin conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.125 ug of Rat IgG2a K Isotype Control APC (left) or 0.125 ug of Anti-Mouse IgM APC (right). Cells in the small scatter](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0002.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Allophycocyanin conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.125 ug of Rat IgG2a K Isotype Control APC (left) or 0.125 ug of Anti-Mouse IgM APC (right). Cells in the small scatter](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0003.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of Biotin conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.06 ug of Rat IgG2a kappa Isotype Control Biotin (left) or 0.06 ug of Anti-Mouse IgM Biotin (right) followed by Streptavidin PE .](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0004.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of FITC conjugate of NBP1-43303. Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.125 ug of Rat IgG2a K Isotype Control FITC (left) or 0.125 ug of Anti-Mouse IgM FITC (right). Total viable cells were used for ana](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0005.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE conjugate of NBP1-43303. The II/41 antibody has been tested by flow cytometric mouse spleen cell suspension. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0006.jpg)
![Flow Cytometry: IgM Antibody (II/41) [NBP1-43303] - Analysis of PE/Cy5 conjugate of NBP1-43303. Staining of C57Bl/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) FITC and 0.06 ug of Rat IgG2a Isotype Control PE-Cy5 (left) or 0.06 ug of Anti-Mouse IgM PE-Cy5 (right). Total viable cells were used for](http://images.novusbio.com/fullsize/Mouse-IgM-Antibody-II-41-Flow-Cytometry-NBP1-43303-img0007.jpg)
![Flow Cytometry: Rat anti-Mouse IgM Secondary Antibody (II/41) [Biotin] [NBP1-43546] - Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.06 ug of Rat IgG2a kappa Isotype Control Biotin (left) or 0.06 ug of Anti-Mouse IgM Biotin (right) followed by Streptavidin PE . Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/Rat-anti-Mouse-IgM-Secondary-Antibody-II-41-Biotin-Flow-Cytometry-NBP1-43546-img0001.jpg "Flow Cytometry: Rat anti-Mouse IgM Secondary Antibody (II/41) [Biotin] [NBP1-43546] - Staining of C57BL/6 bone marrow cells with Anti-Human/Mouse CD45R (B220) APC and 0.06 ug of Rat IgG2a kappa Isotype Control Biotin (left) or 0.06 ug of Anti-Mouse IgM Biotin (right) followed by Streptavidin PE . Total viable cells were used for analysis.")